Clinical Trials Directory

Trials / Completed

CompletedNCT02047240

Renal Function Determination in Patients With Liver Cirrhosis

Renal Function Determination With Creatinine and Cystatin C Dependent Formulas Compared to Gold Standard DTPA-TC-99 (Diethylene-triamine-pentaacetate- Technetium-99) in Mexican Cirrhotic Patients

Status
Completed
Phase
Study type
Observational
Enrollment
92 (actual)
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

We have several ways to appropriately determine renal function in healthy patients and in several diseases, in cirrhotic population we dont have a precise tool that has sufficient precision that reflects glomerular function, although it has been reported that cystatin C, because of its nature could improve diagnostic accuracy to determinate the renal function in this population. The investigators hypothesize that glomerular filtration obtained from cystatin-C-derived formulas are more accurate when compared to creatinine-derived formulas with DTPA-Tc99 (diethylene-triamine-pentaacetate- technetium-99) as gold standard.

Detailed description

The aim of the study is to determine if the formulas for glomerular filtration are close to the estimation of actual renal function in mexican cirrhotic patients of different etiologies.

Conditions

Timeline

Start date
2013-04-01
Primary completion
2015-12-01
Completion
2016-04-01
First posted
2014-01-28
Last updated
2016-06-08

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT02047240. Inclusion in this directory is not an endorsement.